MyAverix Finance
NS · Healthcare
Bacil Pharma Ltd (524516)
Pharmaceuticals & Biotechnology
Bacil Pharma Ltd (524516) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $602.10M, P/E ratio is 38.66, net margin is 47.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524516
Bacil Pharma Ltd (524516) — FAQ
What is Bacil Pharma Ltd's market cap?
Bacil Pharma Ltd (524516) has a reported market cap of $602.10M (data as of 2026-07-10).
What is 524516's P/E ratio?
The price-to-earnings (P/E) ratio for Bacil Pharma Ltd (524516) is 38.66 (data as of 2026-07-10).
Does Bacil Pharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Bacil Pharma Ltd (524516). Check the MyAverix Finance app for the latest dividend data.
What sector is Bacil Pharma Ltd in?
Bacil Pharma Ltd (524516) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524516 listed on?
524516 is listed on NS.
What is Bacil Pharma Ltd's net margin?
Bacil Pharma Ltd (524516) reports a net margin of 47.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.